IsomAb

Nottingham, United Kingdom

IsomAb evaluate and develop isoform specific antibodies to treat disease.

$9.5M raised

Feb 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has IsomAb raised?

IsomAb has raised $9.5M in total funding. The most recent round was Seed. The last funding was announced in February 2024.

Who are IsomAb's investors?

IsomAb's investors include SCVC, Broadview Ventures, MEIF Proof-of-Concept & Early Stage Fund.

Where is IsomAb headquartered?

IsomAb is headquartered in Nottingham, United Kingdom.

What does IsomAb do?

IsomAb evaluate and develop isoform specific antibodies to treat disease.

What stage is IsomAb at?

IsomAb is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 20, 2024.

MLA

"IsomAb — Funding & Investors." VCBacked, February 20, 2024, https://www.vcbacked.co/company/isomab. Accessed July 2, 2026.

APA

VCBacked. (2024). IsomAb — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/isomab

Wikipedia (cite web)

{{cite web |title=IsomAb — Funding & Investors |url=https://www.vcbacked.co/company/isomab |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 20, 2024.